BB Biotech AG operates in the Investors sector.
In addition to historical fundamental analyses, the complete report available to purchase compares BB Biotech AG with three other
financial institutions in Europe:
Gimv Investeringsmaatschappij Voor Vlanderen NV
sales of 141.81 million Euro [US$156.17 million]
of which 43%
was Smart Industries),
(152.87 million Swiss Francs [US$153.95 million]
of which 94%
was Le Coq Sportif), and
Aforti Holding SA
based in Poland
(572.01 million Polish New Zlotys [US$147.09 million]
BB Biotech AG reported sales of 150.99 million Swiss Francs (US$152.06 million)
December of 2018.
decrease of 44.1%
versus 2017, when the company's sales were 270.33 million Swiss Francs.